Atb Cap Markets Lowers Earnings Estimates for Cresco Labs

Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Analysts at Atb Cap Markets dropped their FY2024 earnings per share (EPS) estimates for shares of Cresco Labs in a research note issued to investors on Sunday, November 10th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of ($0.20) per share for the year, down from their prior forecast of ($0.17). The consensus estimate for Cresco Labs' current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Cresco Labs' Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.09) EPS.

CRLBF has been the topic of several other research reports. Roth Capital raised Cresco Labs to a "strong-buy" rating in a research note on Sunday. Ventum Cap Mkts raised shares of Cresco Labs to a "strong-buy" rating in a research report on Friday, August 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cresco Labs in a research report on Monday, August 12th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $2.50.

Cresco Labs Price Performance

Shares of OTCMKTS:CRLBF traded up $0.18 during trading hours on Wednesday, hitting $1.44. 919,928 shares of the company's stock traded hands, compared to its average volume of 752,714. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The company's fifty day simple moving average is $1.58 and its two-hundred day simple moving average is $1.71. Cresco Labs has a 52 week low of $1.02 and a 52 week high of $2.65. The company has a market cap of $702.92 million, a price-to-earnings ratio of -7.10 and a beta of 1.88.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.